Capital Market Days 2018

Zealand will host two Capital Market Days in New York on Thursday 25 January 2018 at 12:30 to 3 pm, followed by an event in Copenhagen on Monday 29 January 2018 1t 13:30.

The Capital Market Days will include an update on the status of Zealand's business and its progress towards becoming a leader in specialty gastrointestinal and metabolic diseases. Management will present the progress and outlook for glepaglutide for the treatment of short bowel syndrome and dasiglucagon for diabetes care and treatment of congenital hyperinsulinsm (CHI) as well as an update on the strong research pipeline.

In addition, we are proud to present two external speakers at the New York event (a recording will be shown at the Danish event):

  • David F. Mercer, M.D., Ph.D., associate professor in the UNMC Department of Surgery-Transplant and director of Nebraska Medicine's Intestinal Rehabilitation Program, will provide important insights regarding the treatment of short bowel syndrome.

  • Jessica Castle, M.D. will provide a clinician perspective of glucagon. Jessica Castle is as an assistant professor at the Harold Schnitzer Diabetes Health Center, Portland.

    Please access web streaming from New York here

    Please find slide presentation here:
    Session 1
    Session 2
    Session 3
    Session 4
    Session 5


Capital Markets Event in Copenhagen

Date: Monday, January 29, 2018

Time: 13:30 - 16:00  CET

Venue: Zealand Pharma, Smedeland 36, 2600 Glostrup

Webcast: This event will not be webcasted, but the presentations from the two key opinion leaders from the New York event will be shown.


SBS video


Jessica Castle


David Mercer